$1.57
-0.05 (-3.09%)
Open$1.65
Previous Close$1.62
Day High$1.65
Day Low$1.55
52W High$6.24
52W Low$1.41
Volume—
Avg Volume43.8K
Market Cap8.75M
P/E Ratio—
EPS$-1.89
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+2,679.6% upside
Current
$1.57
$1.57
Target
$43.64
$43.64
$27.68
$43.64 avg
$53.21
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.60M | 2.77M | 1.47M |
| Net Income | -10,333,194 | -7,175,275 | 533.2K |
| Profit Margin | -287.4% | -273.0% | 36.3% |
| EBITDA | -10,349,634 | -7,585,951 | 838.1K |
| Free Cash Flow | — | — | 521.2K |
| Rev Growth | +29.6% | +29.6% | +11.3% |
| Debt/Equity | 0.02 | 0.02 | 0.46 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,117.26 | +0.92% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $241.00 | +0.80% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $120.60 | +0.84% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.04 | -2.75% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $78.17 | +1.73% | 12.5 | 33.00B |